women's health
Sera Prognostics Goes Public With $75M IPO
The firm is offering 4,687,500 shares of its common stock at $16 per share. Its first commercial product is the PreTRM test for predicting the risk of a preterm birth.
Following Acquisition, UK Firm MyHealthChecked Launches SARS-CoV-2 Consumer Testing Service
The PCR test is the first offering from the firm, formerly known as Concepta, since it acquired Manchester-based startup The Genome Store in November.
Enzo Biochem Q4 Revenues Down 7 Percent
The company said its clinical lab revenues rose nearly 5 percent, but revenues from its life sciences business fell 26 percent because of the COVID-19 pandemic.
Progenity Q2 Revenues Fall 70 Percent in First Earnings Report Since IPO
During the second quarter, the company performed 75,017 tests for noninvasive prenatal testing, carrier screening, and SARS-CoV-2.
Enzo Biochem Q2 Revenues Tick Up Less Than 1 Percent
The company said clinical services revenues and diagnostic testing volumes rose during the quarter, but that PAMA continued to negatively affect reimbursements.